This inventor holds 1 USPTO granted patent. Top assignee: Asta Pharma Aktiengesellschaft. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: Innovations of Johannes Respondek
Johannes Respondek is a notable inventor based in Hanau, Germany. He has made significant contributions to the field of chemistry, particularly in the development of anti-tumor agents. His work has implications for cancer treatment, showcasing the potential of innovative compounds in medical applications.
Latest Patents
Johannes Respondek holds a patent for 1,2-bis(aminomethyl) cyclobutane-platinum complexes. This patent focuses on the anti-tumor activity of these complexes, highlighting their potential effectiveness in cancer therapies. The innovation represents a step forward in the search for effective treatments against various forms of cancer.
Career Highlights
Respondek is associated with Asta Pharma Aktiengesellschaft, a company known for its commitment to pharmaceutical advancements. His role at the company has allowed him to engage in research that bridges the gap between chemistry and medicine. His contributions have been instrumental in the development of new therapeutic agents.
Collaborations
Johannes has collaborated with notable colleagues such as Wolfgang Schumacher and Jurgen Engel. These partnerships have fostered an environment of innovation and creativity, leading to advancements in their respective fields.
Conclusion
In summary, Johannes Respondek is a distinguished inventor whose work in developing anti-tumor compounds has the potential to impact cancer treatment significantly. His collaborations and career at Asta Pharma Aktiengesellschaft further emphasize his commitment to innovation in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile